您的位置: 首页 > 农业专利 > 详情页

USE OF NEUROPILIN-1 (NRP1) AS A CELL SURFACE MARKET FOR THE Isolation of HUMAN HIGH VENTRICULAR STARCELS
专利权人:
Procella Therapeutics AB
发明人:
Chien, Kenneth, R.,CLARKE, Jonathan,LEUNG, Chuen, Yan
申请号:
DK18783080
公开号:
DK3487988T3
申请日:
2018.08.22
申请国别(地区):
DK
年份:
2020
代理人:
摘要:
The present invention provides NRP1 as a cell surface marker for isolating human cardiomyogenic ventricular progenitor cells (HVPs), in particular progenitor cells that preferentially differentiate into cardiac ventricular muscle cells. Additional HVP cell surface markers identified by single cell sequencing are also provided. The invention provides in vitro methods of the separation of NRP1+ ventricular progenitor cells, and the large scale expansion and propagation thereof. Large clonal populations of isolated NRP1+ ventricular progenitor cells are also provided. Methods of in vivo use of NRP1+ ventricular progenitor cells for cardiac repair or to improve cardiac function are also provided. Methods of using the NRP1+ ventricular progenitor cells for cardiac toxicity screening of test compounds are also provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充